102570 Debt/Equity
What is the Debt/Equity of 102570?
The Debt/Equity of 102570 is -1.97
What is the definition of Debt/Equity?
Debt to equity ratio is a financial ratio indicating the relative proportion of shareholders’ equity and debt used to finance a company’s assets.
lfy (last fiscal year)
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Debt/Equity of companies in the Health Care sector on OTC compared to 102570
What does 102570 do?
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. Its products include WellnessPro Plus, a bioelectronics therapy prescription device to relieve chronic and acute pain. Electromedical Technologies, Inc. is headquartered in Scottsdale, Arizona.
Companies with debt/equity similar to 102570
- Sylla Gold Corp has Debt/Equity of -1.98
- TUS International has Debt/Equity of -1.98
- iPic Entertainment has Debt/Equity of -1.97
- iPic Entertainment has Debt/Equity of -1.97
- iPic Entertainment has Debt/Equity of -1.97
- Boostheat SA has Debt/Equity of -1.97
- 102570 has Debt/Equity of -1.97
- Transforma Resources Corporatio has Debt/Equity of -1.97
- Cresval Capital has Debt/Equity of -1.97
- China NT Pharma has Debt/Equity of -1.97
- Pool Safe has Debt/Equity of -1.97
- CannaPharmaRx has Debt/Equity of -1.97
- GCC Global Capital has Debt/Equity of -1.97